Treatment of chronic immune thrombocytopenic purpura in adults

Godeau, Bertrand; Michel, Marc
July 2010
Annals of Hematology;Jul2010, Vol. 89, p55
Academic Journal
Until recently, the management of refractory immune thrombocytopenic purpura (ITP) was a real challenge as shown by the large variety of treatments proposed in both American Society of Hematology and the British Committee for Standards in Haematology guidelines published 10 and 6 years ago, respectively. However, as in the past 5 years, new therapeutic approaches including eradication of Helicobacter pylori in infected patients and rituximab have been proposed and the thrombopoietin-receptor agonists have been developed and licensed for ITP. It is likely that the therapeutic strategy of ITP will be profoundly modified and revisited in the next future. The purpose of this article is to discuss the impact and the place of these new therapeutic options into the whole treatment strategy of chronic ITP and to draw the perspective of new experimental therapies.


Related Articles

  • Effect of Helicobacter pylori eradication in patients with chronic thrombocytopenic purpura. Sato, R.; Murakami, K.; Okimoto, T.; Watanabe, K.; Kodama, M.; Kagawa, J.; Fujioka, T.; Nasu, M. // Gut;Sep2002 Supplement 2, Vol. 51, pA77 

    Background: Although several studies have been investigated the relationship between H. pylori infection and idiopathic thrombocytopenic purpura (ITP), there was no consensus. In this study, we investigated the prevalence of H. pylori infection and the effect of its eradication in patients with...

  • The relationship between immune thrombocytopenic purpura and Helicobacter pylori infection in children: where is the truth? Loffredo, Giuseppe; Marzano, Maria Grazia; Migliorati, Roberta; Miele, Erasmo; Menna, Francesco; Poggi, Vincenzo; Staiano, Annamaria // European Journal of Pediatrics;Oct2007, Vol. 166 Issue 10, p1067 

    This article presents a study on the link between Helicobacter pylori infection and immune thrombocytopenic purpura (ITP) in children. Based on the platelet counts of the children affected by chronic ITP, there is no trend towards improvement in the infected children after the eradication...

  • Chronic, Episodic Thrombocytopenia. McClain, Kenneth L. // Clinical Pediatrics;Mar1990, Vol. 29 Issue 3, p179 

    A male patient with chronic idiopathic thrombocytopenic purpura (ITP) did not fit into any of the known risk groups for chronic ITP. He was unique in that he manifested a cyclic increase of platelet counts each winter followed by a nadir in the summer, without having other hematologic abnormalities.

  • Cytoplasmic fragments of leukaemic cells masquerading as platelets in an automated haematology analyser. Kakkar, N.; Garg, G. // Journal of Clinical Pathology;Feb2005, Vol. 58 Issue 2, p224 

    The article sheds light on the cytoplasmic fragments of leukaemic cells masquerading as platelets in an automated haematology analyser. The accuracy of platelet counts has been a major achievement of automation in haematology laboratories. However, a large array of interfering substances can...

  • Diagnosis and management of chronic ITP: comments from an ICIS expert group. Grainger, John David; Bolton-Maggs, Paula H. B.; Godeau, Bertrand; Bussel, Jim; Donato, Hugo; Elalfy, Mohsen; Hainmann, Ina; Matzdorff, Axel; Müller-Beissenhirtz, Hannes; Rovó, Alicia; Tichelli, Andre; Müller-Beissenhirtz, Hannes; Rovó, Alicia // Annals of Hematology;Jul2010, Vol. 89, p11 

    Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert...

  • Thrombocytopenia and Intravenous Heroin Use. Adams, William H.; Rufo, Robert A.; Talarico, Lilia; Silverman, Stuart L.; Brauer, Mark J. // Annals of Internal Medicine;Aug78, Vol. 89 Issue 2, p207 

    Focuses on a study which dealt with the case of a male heroin user with a syndrome similar to acute immune thrombocytopenic purpura. Epidemiologic considerations of the illness; Results of hematologic laboratory tests; Reasons for the suspicion of toxic basis for thrombocytopenia.

  • Complement profile in childhood immune thrombocytopenic purpura: a prospective pilot study. Ohali, Meli; Maizlishi, Yair; Abramov, Haya; Schlesinger, Menachem; Bransky, David; Lugassy, Gilles // Annals of Hematology;Dec2005, Vol. 84 Issue 12, p812 

    Immune thrombocytopenic purpura (ITP) is a frequent, usually acute hematologic complication of viral diseases in children. Its evolution is usually benign with spontaneous resolution. Some authors have raised the hypothesis of a possible role of the complement system in the pathogenesis of ITP....

  • Immune Thrombocytopenic Purpura. Cines, Douglas B.; Blanchette, Victor S. // New England Journal of Medicine;3/28/2002, Vol. 346 Issue 13, p995 

    Presents a review that focuses on the diagnosis and management of primary immune thrombocytopenic purpura, an auto immune disorder characterized by a low platelet count and mucocutaneous bleeding. Description of the disorder and its occurrence in children and adults; Possible causes of the...

  • Essential thrombocythemia. Brière, Jean B. // Orphanet Journal of Rare Diseases;2007, Vol. 2, p3 

    Essential thrombocythemia (ET) is an acquired myeloproliferative disorder (MPD) characterized by a sustained elevation of platelet number with a tendency for thrombosis and hemorrhage. The prevalence in the general population is approximately 30/100,000. The median age at diagnosis is 65 to 70...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics